Tessa Therapeutics Competitors and Similar CompaniesClear all

Gradalis's competitors and similar companies include Immatics and Cryo-Cell.
Gradalis
Gradalis
Gradalis is a biotechnology company focused on the development and commercialization of personalized therapeutics to treat cancer.
Immatics
Immatics
Immatics is a biotechnology company that is primarily engaged in the research and development of T cell redirecting immunotherapies for the treatment of cancer.
Cryo-Cell
Cryo-Cell
Cryo-Cell International is a provider of cord blood banking and cord tissue storage services.
Founding Date
Founding Date
2003
Founding Date
N/A
Founding Date
1989
Type
Type
Private
Type
Public
Type
Public
Tags
Locations
Locations
Carrollton, US HQ
Locations
Tübingen, DE HQ
Frankfurt Am Main, DE
München, DE
Houston, US
Locations
Oldsmar, US HQ
Santiago, CL
San Pedro Sula, HN
Guadalajara, MX
Panamá City, PA
North Miami Beach, US
Caracas, VE
Employees
Employees
25
Employees
29723% increase
Employees
804% decrease
Valuation ($)
Valuation ($)
N/A
Valuation ($)
1.1 b
Valuation ($)
47.9 m

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
€48.3m (FY, 2025)
Revenue (est.)
$31.6m (FY, 2025)
Cost of goods
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$7.4m (FY, 2025)
Gross profit
Gross profit
N/A
Gross profit
€53m (FY, 2025)
Gross profit
$24.2m (FY, 2025)
Net income
Net income
N/A
Net income
(€196.4m) (FY, 2025)
Net income
($2.4m) (FY, 2025)

Funding

Total funding raised
Total funding raised
$ 67.9m
Total funding raised
$ 267.3m
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Immatics
HQ
Tübingen, DE
Employees
297↑ 23% increase

Immatics is a biotechnology company that is primarily engaged in the research and development of T cell redirecting immunotherapies for the treatment of cancer.

View company
Cryo-Cell
HQ
Oldsmar, US
Employees
80↓ 4% decrease

Cryo-Cell International is a provider of cord blood banking and cord tissue storage services.

View company